INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 44h ago
House PTR4h ago
SEC 13F4h ago
Robinhood Chain4h ago

Most active filers · 30d

  1. 01FWFogarty Patrick W0B / 206S206 trades$1.10M
  2. 02Kurtz George0B / 202S202 trades$48.06M
  3. 03SPSaba Capital Management, L.P.67B / 19S · 11 late86 trades$21.51M
  4. 04NYNissan Yitzhak82B / 0S · 79 late82 trades$2.61M
  5. 05ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  6. 06AJAllaire Jeremy0B / 50S50 trades$4.26M
  7. 07Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  8. 08SJSheena Jonathan0B / 45S45 trades$3.01M
  9. 09SISarowitz Steven I2B / 34S36 trades$21.18M
  10. 10SLSpeiser Michael L0B / 35S35 trades$14.00M

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 1732 insiders$917K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 179 insiders$893K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 168 insiders$42.58M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLMGNIMAGNITE, INC.Nov 5 – Nov 178 insiders$2.77M
  7. SELLIBEXIBEX LtdNov 9 – Nov 167 insiders$3.36M
  8. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M

Form 4 transactions

73,372 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
13
CM
Cairns MichaelChief Credit Officer
LOBLive Oak Bancshares, Inc.
Option exercise
M—
943 sh
Dec 9, 2025Dec 10, 2025
Page 1656 of 1835
← PrevNext →
traded Dec 9, 2025
+1d
SEC Form 4

Evidence

13
CC
Culloty Maeve CEVP, Pres & CEO Financial Serv
HPEHewlett Packard Enterprise Co
Tax withholding
F$19K
811 sh
Dec 8, 2025Dec 10, 2025
traded Dec 8, 2025
+2dSEC Form 4

Evidence

13
GF
Goins Melanie FGeneral Counsel and CPO
DIBS1stdibs.com, Inc.
Option exercise
M—
10.0K sh
Dec 8, 2025Dec 10, 2025
traded Dec 8, 2025
+2dSEC Form 4

Evidence

13
BV
Bulho Matheus De A G VieraSVP Software and Control
ROKROCKWELL AUTOMATION, INC
Open-market sale · 10b5-1 plan
SELL$6,028
15 sh
Dec 8, 2025Dec 10, 2025
traded Dec 8, 2025
+2dSEC Form 4

Evidence

13
BV
Bulho Matheus De A G VieraSVP Software and Control
ROKROCKWELL AUTOMATION, INC
Open-market sale · 10b5-1 plan
SELL$43K
108 sh
Dec 10, 2025Dec 10, 2025
traded Dec 10, 2025
+0dSEC Form 4

Evidence

13
MM
Moroz Mark MichaelChief Banking Officer
LOBLive Oak Bancshares, Inc.
Tax withholding
F$42K
1,258 sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC Form 4

Evidence

13
MP
Murphy PamDirector
ROKROCKWELL AUTOMATION, INC
Grant or award
A—
498 sh
Dec 8, 2025Dec 10, 2025
traded Dec 8, 2025
+2dSEC Form 4

Evidence

13
CM
Cairns MichaelChief Credit Officer
LOBLive Oak Bancshares, Inc.
Tax withholding
F$14K
421 sh
Dec 8, 2025Dec 10, 2025
traded Dec 8, 2025
+2dSEC Form 4

Evidence

13
BV
Bulho Matheus De A G VieraSVP Software and Control
ROKROCKWELL AUTOMATION, INC
Open-market sale · 10b5-1 plan
SELL$8,486
21 sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC Form 4

Evidence

13
GP
Gipson William PDirector
ROKROCKWELL AUTOMATION, INC
Grant or award
A—
498 sh
Dec 8, 2025Dec 10, 2025
traded Dec 8, 2025
+2dSEC Form 4

Evidence

13
PJ
Phifer Walter JChief Financial Officer
LOBLive Oak Bancshares, Inc.
Tax withholding
F$24K
729 sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC Form 4

Evidence

12
VV
Valenzuela VictoriaCALO & Corp. Secretary
APPAppLovin Corp
Gift
G—
5,500 sh
Dec 10, 2025Dec 10, 2025
traded Dec 10, 2025
+0dSEC Form 4

Evidence

12
RV
Raghunathan VivekSVP, Engineering and Support
SNOWSnowflake Inc.
Tax withholding
F$125K
545 sh
Dec 8, 2025Dec 10, 2025
traded Dec 8, 2025
+2dSEC Form 4

Evidence

12
CD
Chudova DaryaChief Technology Officer
GHGuardant Health, Inc.
Other acquisition or disposition
J—
68.1K sh
Dec 8, 2025Dec 10, 2025
traded Dec 8, 2025
+2dSEC Form 4

Evidence

12
SF
Schaufeld FredrickDirector
TLSTELOS CORP
Gift
G—
35.0K sh
Dec 8, 2025Dec 10, 2025
traded Dec 8, 2025
+2dSEC Form 4

Evidence

12
HS
Herseth Mary Jo S.Director
BYBYLINE BANCORP, INC.
Other acquisition or disposition
J—
18.5K sh
Dec 10, 2025Dec 10, 2025
traded Dec 10, 2025
+0dSEC Form 4

Evidence

12
AJ
Allan JonathanGENERAL COUNSEL & CORP SEC
STOKStoke Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$41K
1,300 sh
Dec 8, 2025Dec 10, 2025
traded Dec 8, 2025
+2dSEC Form 4

Evidence

12
HS
Herseth Mary Jo S.Director
BYBYLINE BANCORP, INC.
Other acquisition or disposition
J—
18.5K sh
Dec 10, 2025Dec 10, 2025
traded Dec 10, 2025
+0dSEC Form 4

Evidence

12
DJ
Daunt JohnEVP, Chief Commercial Officer
LQDTLIQUIDITY SERVICES INC
Gift
G—
1,660 sh
Dec 8, 2025Dec 10, 2025
traded Dec 8, 2025
+2dSEC Form 4

Evidence

12
TJ
Tobin Richard JChairman, President & CEO
DOVDOVER Corp
Gift
G—
2,617 sh
Dec 8, 2025Dec 10, 2025
traded Dec 8, 2025
+2dSEC Form 4

Evidence

12
TA
Talasaz AmirAliDirector, Co-Chief Executive Officer
GHGuardant Health, Inc.
Other acquisition or disposition
J—
387.9K sh
Dec 8, 2025Dec 10, 2025
traded Dec 8, 2025
+2dSEC Form 4

Evidence

12
CD
Chudova DaryaChief Technology Officer
GHGuardant Health, Inc.
Other acquisition or disposition
J—
68.1K sh
Dec 8, 2025Dec 10, 2025
traded Dec 8, 2025
+2dSEC Form 4

Evidence

12
CA
Chakravarthy ArthiChief Legal Officer
ENVXEnovix Corp
Gift
G—
2,777 sh
Dec 8, 2025Dec 10, 2025
traded Dec 8, 2025
+2dSEC Form 4

Evidence

11
KM
Kim Joo MiCHIEF FINANCIAL OFFICER
QLYSQUALYS, INC.
Open-market sale · 10b5-1 plan
SELL$493K
3,296 sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC Form 4

Evidence

11
CK
Choudary Kiran KumarChief Financial Officer
RBRKRubrik, Inc.
Open-market sale · 10b5-1 plan
SELL$18K
200 sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC Form 4

Evidence

11
CK
Choudary Kiran KumarChief Financial Officer
RBRKRubrik, Inc.
Open-market sale · 10b5-1 plan
SELL$18K
200 sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC Form 4

Evidence

11
CK
Choudary Kiran KumarChief Financial Officer
RBRKRubrik, Inc.
Open-market sale · 10b5-1 plan
SELL$37K
400 sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC Form 4

Evidence

11
KM
Kim Joo MiCHIEF FINANCIAL OFFICER
QLYSQUALYS, INC.
Open-market sale · 10b5-1 plan
SELL$625K
4,153 sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC Form 4

Evidence

11
BS
Baig SaqibChief Accounting Officer
PTONPELOTON INTERACTIVE, INC.
Open-market sale · 10b5-1 plan
SELL$32K
5,000 sh
Dec 8, 2025Dec 10, 2025
traded Dec 8, 2025
+2dSEC Form 4

Evidence

11
RR
Remer Eric RichardDirector, Chief Executive Officer
EVCMEverCommerce Inc.
Open-market sale · 10b5-1 plan
SELL$40K
4,004 sh
Dec 10, 2025Dec 10, 2025
traded Dec 10, 2025
+0dSEC Form 4

Evidence

10
RM
Ragosa MarkCHIEF FINANCIAL OFFICER
KNSAKiniksa Pharmaceuticals International, plc
Option exercise · 10b5-1 plan
M$179K
16.2K sh
Dec 8, 2025Dec 10, 2025
traded Dec 8, 2025
+2dSEC Form 4

Evidence

10
BV
Bulho Matheus De A G VieraSVP Software and Control
ROKROCKWELL AUTOMATION, INC
Option exercise · 10b5-1 plan
M$335K
1,289 sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC Form 4

Evidence

9
PM
Patel Ketan MPresident, Personal Systems
HPQHP INC
Grant or award
A—
77.5K sh
Dec 8, 2025Dec 10, 2025
traded Dec 8, 2025
+2dSEC Form 4

Evidence

9
HE
Ho EmilyChief Accounting Officer
SNOWSnowflake Inc.
Tax withholding
F$42K
182 sh
Dec 8, 2025Dec 10, 2025
traded Dec 8, 2025
+2dSEC Form 4

Evidence

9
UA
Uggetti AlbertoEVP & CCO
ULSUL Solutions Inc.
Grant or award
A—
5 sh
Dec 8, 2025Dec 10, 2025
traded Dec 8, 2025
+2dSEC Form 4

Evidence

9
SS
Seyedkazemi SetarehCHIEF DEVELOPMENT OFFICER
ADVMAdverum Biotechnologies, Inc.
Disposition to issuer
D—
40.0K sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC Form 4

Evidence

9
GA
Genovesi John ASee Remarks
ULSUL Solutions Inc.
Grant or award
A—
6 sh
Dec 8, 2025Dec 10, 2025
traded Dec 8, 2025
+2dSEC Form 4

Evidence

9
CC
Culloty Maeve CEVP, Pres & CEO Financial Serv
HPEHewlett Packard Enterprise Co
Grant or award
A—
57.6K sh
Dec 8, 2025Dec 10, 2025
traded Dec 8, 2025
+2dSEC Form 4

Evidence

9
DA
Dadakis AlexSee Remarks
ULSUL Solutions Inc.
Grant or award
A—
8 sh
Dec 8, 2025Dec 10, 2025
traded Dec 8, 2025
+2dSEC Form 4

Evidence

9
PA
Patel AnishCHIEF OPERATING OFFICER
ELVNEnliven Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$103K
4,958 sh
Dec 8, 2025Dec 10, 2025
traded Dec 8, 2025
+2dSEC Form 4

Evidence